Also trades as: 1093.HK (HKSE) · $vol 130M · CHJTF (OTC) · $vol 0M

$5.10

+0.40 (+8.51%)

Weekly Expected Move ±9.5%

$4 $5 $5 $6 $6

OTC · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 74 · $14.7B mcap · 2.88B float · 0.0001% daily turnover · Short 17% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$28.2B -8.8% ▼

5Y CAGR: -1.0%

Gross Profit

$18.5B -14.5% ▼

5Y CAGR: -2.5%

Operating Income

$4.3B -24.7% ▼

5Y CAGR: -7.9%

Net Income

$4.2B -8.7% ▼

5Y CAGR: -4.0%

EPS (Diluted)

$1.48 -5.1% ▼

5Y CAGR: -6.2%

EBITDA

$5.8B -15.1% ▼

5Y CAGR: -6.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$34.2B	$35.0B	$34.6B	$30.9B	$28.2B
YoY Growth	+15.4%	+2.4%	-1.2%	-10.8%	-8.8%
Cost of Revenue	$8.1B	$8.9B	$10.2B	$9.3B	$9.7B
Gross Profit	$25.5B	$22.7B	$24.4B	$21.6B	$18.5B
Gross Margin	74.5%	64.9%	70.5%	70.0%	65.6%
R&D Expenses	$4.2B	$4.6B	$5.3B	$5.5B	$6.3B
SG&A Expenses	$14.1B	$13.0B	$11.4B	$10.4B	$7.9B
Operating Expenses	$18.3B	$17.6B	$16.7B	$15.9B	$14.2B
Operating Income	$7.7B	$7.6B	$7.7B	$5.7B	$4.3B
Operating Margin	22.4%	21.7%	22.2%	18.5%	15.3%
Interest Expense	$8M	$25M	$26M	$44M	$42M
Income Before Tax	$8.4B	$8.6B	$7.4B	$5.9B	$5.2B
Tax Expense	$1.4B	$1.4B	$1.3B	$1.3B	$1.0B
Net Income	$6.9B	$6.9B	$5.9B	$4.6B	$4.2B
Net Margin	20.1%	19.7%	17.0%	14.9%	14.9%
EPS (Diluted)	$1.88	$2.04	$2.00	$1.56	$1.48
EBITDA	$9.3B	$8.7B	$8.5B	$6.9B	$5.8B
Shares Outstanding	2.99B	2.98B	2.97B	2.93B	2.86B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$15.1B	$8.0B	$7.6B	$16.3B	$14.6B	$1.8B	$12.5B	$18.4B
Cost of Revenue	$4.3B	$2.3B	$7.9B	$4.6B	$4.6B	$629M	$4.3B	$4.4B
Gross Profit	$10.8B	$5.7B	$18.7B	$11.6B	$10.0B	$1.2B	$8.2B	$14.0B
Gross Margin	71.2%	71.2%	246.3%	71.6%	68.2%	65.6%	65.6%	76.2%
R&D Expenses	$1.1B	$1.3B	$1.2B	$2.5B	$3.0B	$2.9B	$3.1B	$3.0B
SG&A Expenses	$6.3B	$5.9B	$5.4B	$5.8B	$4.6B	$3.8B	$3.7B	$3.7B
Operating Expenses	$8.7B	$5.7B	$3.6B	$8.4B	$7.5B	$6.7B	$6.8B	$6.7B
Operating Income	$1.6B	$0	$1.8B	$3.7B	$2.0B	$354M	$1.4B	$7.3B
Operating Margin	10.5%	0.0%	23.6%	22.7%	13.8%	19.4%	11.0%	39.5%
Interest Expense	$15M	$6M	$9M	$0	$0	$3M	$17M	$13M
Income Before Tax	$3.8B	$1.9B	$1.8B	$3.8B	$2.1B	$430M	$1.7B	$7.4B
Tax Expense	$648M	$312M	$1.0B	$749M	$570M	$596M	$381M	$1.1B
Net Income	$1.6B	$1.5B	$1.4B	$3.0B	$1.6B	$351M	$1.3B	$6.0B
Net Margin	10.8%	19.2%	18.2%	18.5%	10.9%	19.2%	10.5%	32.8%
EPS (Diluted)	$1.00	$0.52	$1.44	$1.08	$0.48	$0.12	$0.48	$2.12
EBITDA	$2.6B	$1.9B	$1.8B	$4.5B	$2.5B	$3.5B	$2.1B	$7.9B
Shares Outstanding	2.98B	2.98B	2.96B	2.96B	2.93B	2.86B	2.88B	2.85B

CSPCY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet